Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
16 hedge funds and large institutions have $694K invested in Intellipharmaceuticals International Inc. in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
3% more capital invested
Capital invested by funds: $673K → $694K (+$21K)
11% less funds holding
Funds holding: 18 → 16 (-2)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
95% less call options, than puts
Call options by funds: $10K | Put options by funds: $191K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$5.6K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.58K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$195 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$29K |
| 2 |
Morgan Stanley
New York
|
-$7.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$58 |
IPCI Hedge Fund Activity: Q4 2015 in Review
16 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q4 2015, worth a combined $694K — up 3.1% from $673K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IPCI and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Simplex Trading, adding an estimated $5.6K. The largest seller was First Midwest Bank Trust Division, exiting entirely with an estimated $29K sold.
- 16 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q4 2015, down from 18 in Q3 2015.
- Funds reported $694K of Intellipharmaceuticals International Inc. stock for Q4 2015, up 3.1% quarter-over-quarter.
- 2 funds opened new Intellipharmaceuticals International Inc. positions in Q4 2015 and 4 closed out, a net change of -2 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q4 2015 was Simplex Trading, an estimated $5.6K added.
- The largest Intellipharmaceuticals International Inc. seller in Q4 2015 was First Midwest Bank Trust Division, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2015.